Travere Therapeutics has announced a common stock offering, but before we dive into the details, it’s important to note that the information provided here is based on backtested results. This means that the performance data is not indicative of actual future results. The results are from a model that was not historically available to investors, so it does not represent what any actual investor would have achieved.
The backtested results are calculated by applying a model to historical data and making certain assumptions. These assumptions include the ability of a hypothetical firm to purchase the recommended securities and the liquidity of the markets for trading. It’s important to understand that changes in these assumptions can significantly impact the backtested returns.
It’s also worth mentioning that certain assumptions are made for modeling purposes and may not actually come to fruition. This information is meant for illustrative purposes only, and backtested performance has its limitations. For example, it does not take into account actual trading or the influence of economic and market factors on decision-making.
Since trades were not actually executed, the results may not fully account for certain market factors like liquidity. Additionally, backtesting allows for adjustments to the security selection methodology to maximize past returns, which may not reflect actual performance.
The backtested results are adjusted to include the reinvestment of dividends and other income. They are presented gross of fees and do not consider transaction costs, management fees, performance fees, or expenses. It’s important to consider regulatory considerations when presenting fees.
In conclusion, while Travere Therapeutics has announced a common stock offering, it’s essential to approach the information with caution due to the nature of backtested results. Actual performance may vary significantly from what is presented here. It’s always wise to conduct thorough research and consult with a financial advisor before making any investment decisions.
